• 대한한의학방제학회지
• /
• 제26권2호
• /
• pp.123-127
• /
• 2018

Objective : This research was performed In order to establish the standard of the proper and taste in Korean Medicine. Methods : The change of the proper and taste of Mahwang(麻黃), Gyeji(桂枝), Jagyak(芍藥) and the change of the interpretation of the effect was investigated literally. Results : The hypotheses could be induced as follows. The pungent taste of Mahwang(麻黃) and the sweet taste of Gyeji(桂枝) was inserted by Bonchogyeongso(本草經疏) in Ming Dynasty. In case of Jagyak(芍藥), the proper and taste was changed into sour and cold at Myeonguibyeollok(名醫別錄). It can be proposed that bitter, warm of Mahwang(麻黃), the pungent and warm of Gyeji(桂枝) and the bitter and neutral of Jagyak(芍藥) in Sinnongbonchogyeong(神農本草經) is the adequate proper and taste Conclusions : Therefore it can be hypothesized that the taste and property of Sinnongbonchogyeong(神農本草經) can be established as the standard of the taste and property of Korean Medicine. But in the case of Baekduong(白頭翁), there is the fault of transcribing. So the caution is needed to decide the adequate taste and property.

• 대한한의학원전학회지
• /
• 제23권2호
• /
• pp.191-203
• /
• 2010

"Bonchogyeongjipju(本草經集注)" is a pharmacological classic published in the Southern and Northern Dynasties(南北朝時代, 420-589 A.D.) in China by Dohonggyeong(陶弘景, 456-536 A.D.). In "Bonchogyeongjipju(本草經集注)", Dohonggyeong(陶弘景) edited "Sinnongbonchogyeong(神農本草經)", the earliest classical text about material medica containing notes for 365 drugs, by adding another 365 drugs and further information from "Myeong-uibyeollok(名醫別錄)" and writing extended commentaries on them. His commentaries include changes in the geographical distribution, identification of varieties and other various special characteristics. The original text had gradually disappeared after other pharmacological classics were published such as "Sinsuboncho(新修本草)", in Dang Dynasty(唐代), "Gyeongsajeungryubigeupboncho(經史證類備急本草)" in Song Dynasty(宋代). All of these books were based on "Bonchogyeongjipju(本草經集注)", so the original text can be seen indirectly through these later sources. In the early 1900's, a transcribed manuscript of the preface "Bonchogyeongjipju(本草經集注)" was found almost wholly preserved except the first three lines, in the Makgo(莫高) cave of Donhwang(敦煌). Broken strips of transcribed "Bonchogyeongjipju(本草經集注)" have also been excavated in Turfan[吐魯番], which shows its original form written in red and black ink. Mayanagi Makoto[眞柳誠] researched on Donhwang(敦煌) and Turfan[吐魯番] editions, ascertained their existence and explained their bibliographical and historical facts. Sangjigyun(尙志鈞) restored "Bonchogyeongjipju(本草經集注)" based on other related sources such as Donhwang(敦煌) and Turfan[吐魯番] editions. " Bonchogyeongjipju(本草經集注)" can be said as the locus classicus(典範) of herbal medicine, that is most of the following materia medica was based on it. It makes it possible to pass down "Sinnongbonchogyeong(神農本草經)" to posterity and provide a foundation for herbal medical development.

• 대한한의학원전학회지
• /
• 제21권3호
• /
• pp.273-283
• /
• 2008

"神農本草經"又叫本經, 本草經, 神農本經等簡稱. 它的出現年代是各學者主張不相同, 而且其輯復的原始本也不同. 其書早期亡失所以明 淸代醫家或金石學家輯復, 而才我們能看到斟酌本草經原貌. 可是無可奈何輯復的內容各本每不完美少有缺點. 關於"神農本草經"的硏究內容方面, 最近中國和日本的學者們已經得了不少的對"神農本草經"的硏究成果. 但是在韓國的情況仍然沒有這種學術結果. 所以首先鍼對"神農本草經"輯復的人物最早重視的"本草綱目"爲硏究目標. "本草綱目 序例 歷代諸家本草"當中有與"神農本草經"有關的本草書籍內容中選錄 "神農本草經","名醫別錄","棟君采藥錄","雷公藥對","李當之本草","吳普本草"條文. 其內容不但很有興趣, 而且載比較的多的情報. 因此在此討論一些關聯本草經的問題, 能够發展進一步藥物學的成就.

• 대한한의학원전학회지
• /
• 제23권3호
• /
• pp.81-101
• /
• 2010

The results of researching Jang's use of herb remedies through his book "Uihakchungjungchamseorok(醫學衷中參西錄)" are as follows. 1. Jang Seoksun's medicine is based on "Hwangjenaegyeong(黃帝內經)", "Sanghanron(傷寒論)", "Sinnongbonchogyeong(神農本草經)". And through constant study he brought to perfection his own unique medical theory. 2. He introduced Western medicine, and united it with traditional Chinese medicine. He perfected the Chinese-Western medical theory, by Chungjungchamseo(衷中參西) which means 'roots in traditional Chinese medicine, reference in Western medicine'. 3. He thought Onbyeong(溫病) was not an independent category of disease, but included it into the category of Sanghan(傷寒). So he used modified prescription of "Sanghanron(傷寒論)" to treat Onbyeong(溫病). 4. He expanded the category of remedy uses by using various compounds, such as minerals and animal compounds. He has also developed substitute remedies.

• 대한한의학방제학회지
• /
• 제15권2호
• /
• pp.9-19
• /
• 2007

Nineteen Medicaments of Mutual Antagonism currently belong to pharmaceutical incompatibility and some of them cannot be used in a same prescription: if they are used in a prescription, the treatment effect is rather reduced or toxic response may be produced. Therefore. inthisstudy, it was intended to look about how Nineteen Medicaments of Mutual Antagonism were defined through survey of literatures and to review the meaning and clinical potential. According to "Sinnongbonchogyeong," "Medicaments contain the substance that suppress toxins and the toxins may be removed with use of mutual restraint or mutual detoxication substances" and they have been used in terms of this concept. Since Tang and Song era, mutual restraint and mutual inhibition were confused and were difficult to be distinguished. In terms of pharmaceutical incompatibility, the original meaning of mutual restraint was deteriorated in "Sinnongbonchogyeong". That is. mutual restraint has been used as the concept of mutual inhibition or incompatibility. When various literatures were reviewed. it could be found that Nineteen Medicaments of Mutual Antagonism were firstly included in the phrases of songs and then in "seven emotion." It could be supposed that Nineteen Medicaments of Mutual Antagonism was created based on the clinical experiences of the author and the influence of doctors. Such supposition means indicates that the interactions among medicaments could effectively be applied and mutual restraint did not belong to pharmaceutical incompatibility. However. many doctors used mutual restraint and mutual inhibition in clinical practice with no distinguishment since Song era and. especially, it is supposed that. when medicaments were used with mixing. the pharmaceutical incompatibility of "Nineteen Medicaments of Mutual Antagonism" or "Eighteen Incompatible Medicaments" were emphasized and influenced on the efficacy of pharmaceutical preparations or acted as an obstacle in treating diseases. That is. an error was transferred: mutual restraint and mutual inhibition were not distinguished and were discretionally added or deleted through common people or professionals with no specific verification. The pharmaceutical preparations that belong to Nineteen Medicaments of Mutual Antagonism belong to pharmaceutical incompatibility but. when reviewed various literatures and clinical reports. they are not thought to be the ones that can never be used. Therefore. systematic literature review and experimental research should be performed.

• 한방안이비인후피부과학회지
• /
• 제20권2호통권33호
• /
• pp.132-141
• /
• 2007

Objectives : The purpose of this study is to consider the definition, history, classification and clinical effect of balneotherapy. Methods : We researched oriental documents and recent sources of balneotherapy. Results and Conclusions : 1. Balneotherapy is medical cure method which uses physical chemistry effects of water. 2. Records of balneotherapy are seen in oriental documents such as Hwangjenaegyeong(黃帝內經), Sinnongbonchogyeong(神農本草經), Jaebyoungwonhuron(諸病源候論), Youmoonsachin(儒門事親), Bonchogangmok(本草綱目) and Donguibogam(東醫寶鑑) etc. 3. Spa can classify eleven types according to ingredient. The types were as following. Simple thermal spirng, Common salt spring, Sodium bicarbonated spring, Sulfate spring, Radioactive spring, Acid spring, Sulfur spring, Carbon dioxide spring, Iron spring, Alum spring & Sulfate-iron spring, Bicarbonatealkaline spring. 4. Physical, chemical and environmental effect of spa therapy have effectiveness on the chronic and we akness disease more than acute disease. And balneotherapy have more effectiveness on digestive disease, pulmonary disease, metabolic disease, circulatory disease, muscle skeletal disease and dermatologic disease than any other diseases.